These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22216505)

  • 1. Factors influencing the absorption and disposition of mecillinam and pivmecillinam in man.
    Andrews J; Kendall MJ; Mitchard M
    Br J Clin Pharmacol; 1976 Aug; 3(4):627-32. PubMed ID: 22216505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of mecillinam and pivmecillinam in pregnant and non-pregnant women.
    Heikkilä A; Pyykkö K; Erkkola R; Iisalo E
    Br J Clin Pharmacol; 1992 Jun; 33(6):629-33. PubMed ID: 1389936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion of mecillinam by volunteers receiving film-coated tablets of pivmecillinam hydrochloride.
    Anderson JD; Adams MA
    Chemotherapy; 1979; 25(1):1-4. PubMed ID: 217572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of bacmecillinam and pivmecillinam in volunteers.
    Josefsson K; Bergan T; Magni L; Pring BG; Westerlund D
    Eur J Clin Pharmacol; 1982; 23(3):249-52. PubMed ID: 6293834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LC-MS/MS methods for determination of unstable pivmecillinam and mecillinam in acidified human plasma: Application to a pharmacokinetic study.
    Sun LN; Zhao Y; Gao HY; Yang YL; Qian XP; Sun SY; Wang Y; Ding L; Wang YQ
    J Sep Sci; 2022 Jul; 45(14):2543-2554. PubMed ID: 35593582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic studies with mecillinam and pivmecillinam.
    Roholt K; Nielsen B; Kristensen
    Chemotherapy; 1975; 21(3-4):146-66. PubMed ID: 1157572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum concentrations and penetration into prostate of mecillinam and ampicillin.
    Jeppesen N; Frimodt-Møller C
    Curr Med Res Opin; 1984; 9(3):213-8. PubMed ID: 6499514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational change of CTX-M-15 to CTX-M-127 resulting in mecillinam resistant Escherichia coli during pivmecillinam treatment of a patient.
    Nielsen KL; Hansen KH; Nielsen JB; Knudsen JD; Schønning K; Frimodt-Møller N; Hertz FB; Jansåker F
    Microbiologyopen; 2019 Dec; 8(12):e941. PubMed ID: 31573735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentrations and excretion of mecillinam after oral administration of pivmecillinam in elderly patients.
    Ball AP; Viswan AK; Mitchard M; Wise R
    J Antimicrob Chemother; 1978 May; 4(3):241-6. PubMed ID: 209010
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro susceptibility to mecillinam of Escherichia coli strains isolated from the urine of pregnant women.
    Duployez C; Loiez C; Cattoen C; Descamps D; Wallet F; Vachée A;
    Med Mal Infect; 2016 Dec; 46(8):436-441. PubMed ID: 27609597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of pivmecillinam.
    Parsons RL; Hossack GA; Paddock GM
    Br J Clin Pharmacol; 1977 Jun; 4(3):267-73. PubMed ID: 197981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pivmecillinam, co-trimoxazole and oral mecillinam in gastroenteritis due to Vibrio spp.
    Uylangco C; Santiago L; Pescante M; Menday P; Christensen O
    J Antimicrob Chemother; 1984 Feb; 13(2):171-5. PubMed ID: 6323378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mecillinam resistance and outcome of pivmecillinam treatment in uncomplicated lower urinary tract infection in women.
    Monsen TJ; Holm SE; Ferry BM; Ferry SA
    APMIS; 2014 Apr; 122(4):317-23. PubMed ID: 24738161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of food on bioavailability of amdinocillin pivoxil.
    Bornemann LD; Castellano S; Lin AH; Enthoven D; Patel IH
    Antimicrob Agents Chemother; 1988 Apr; 32(4):592-4. PubMed ID: 3377469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging clinical role of pivmecillinam in the treatment of urinary tract infections caused by Extended Spectrum βeta-lactamase (ESBL) producing Enterobacteriaceae.
    Raja NS
    Int J Clin Pract; 2019 Sep; 73(9):1-5. PubMed ID: 31243859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study on clinical effectiveness of mecillinam and pivmecillinam versus ampicillin in acute urinary infections (author's transl)].
    Seppelt U; Bertermann H; Sonntag HG
    Arzneimittelforschung; 1982; 32(5):569-71. PubMed ID: 6285939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of subinhibitory concentrations of mecillinam on the serum susceptibility of Escherichia coli strains.
    Taylor PW; Gaunt H; Unger FM
    Antimicrob Agents Chemother; 1981 May; 19(5):786-8. PubMed ID: 6271047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Amidinopenicillins (mecillinam and pivmecillinam). A new group of beta-lactamate antibiotics].
    Melby K; Rollag H
    Tidsskr Nor Laegeforen; 1980 Jan; 100(2):105-6. PubMed ID: 6246655
    [No Abstract]   [Full Text] [Related]  

  • 19. Characteristics of gram-negative urinary tract infections caused by extended spectrum beta lactamases: pivmecillinam as a treatment option within South Dublin, Ireland.
    O'Kelly F; Kavanagh S; Manecksha R; Thornhill J; Fennell JP
    BMC Infect Dis; 2016 Nov; 16(1):620. PubMed ID: 27806687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mecillinam serum levels following intravenous injection: a comparison with pivmecillinam.
    Mitchard M; Andrews J; Kendall MJ; Wise R
    J Antimicrob Chemother; 1977 Jul; 3 Suppl B():83-8. PubMed ID: 893249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.